Gene Query: ITGA6

Dataset Description Geneva Score
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 91.96
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 91.96
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 89.73
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 80.09
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 71.9
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 71.9
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 69.63
Transcriptome analysis of BAP1 knockout and restoration 69.37
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 69.37
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 65.68
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 65.39
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 65.39
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 64.07
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 63.38
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 62.89
STRIPAK directs PP2A activity to promote oncogenic transformation 62.79
Inhibition of TNBC metastasis by Gpx1 62.5
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 59.21
RNA-seq of young and quiescent MRC-5 human fibroblasts 59.15
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 58.14
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 56.94
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 55.95
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 55.06
RNA-Seq from early time points in the kidney differentiation protocol 54.56
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 54.28
RNA-Seq analysis of breast cancer cells after shikonin treatment 52.54
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 52.27
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 52.22
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 51.79
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 51.79
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 51.57
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 50.92
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 50.49
Generation of trichogenic adipose-derived stem cells by expression of three factors 50.06
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 50.0
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 50.0
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 49.84
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 48.95
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 47.72
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 46.74
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 46.05
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 46.05
Differential gene expression in Jagged1 treated human dental pulp cells. 45.91
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 45.69
BET bromodomain inhibition 45.08
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 45.08
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 45.02
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 44.52
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 43.16
RNA sequencing analysis of human embryonic stem cells and axial progenitors 41.69
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 40.91
RNA-seq analyses of human prostate cancer cells 40.78
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 40.53
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 40.43
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 40.33
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 39.87
Differential Gene Expression between MCF10A and MCF7 cells 39.76
Expression level comparison under dividing and quiescent states in human primary fibroblasts 39.73
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 39.48
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 39.47
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 39.47
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 38.72
Lipid degradation promotes prostate cancer cell survival 38.3
A prostate cancer chromatin interaction map 38.08
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 37.82
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 37.8
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 37.32
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 37.29
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 36.61
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 36.28
TCF7L1 knockdown in pancreatic cancer 36.27
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 35.62
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 34.99
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 34.92
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 34.92
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 34.9
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 34.69
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 34.44
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 34.31
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 34.2
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 34.15
RNA-seq analysis to identify the genes regulated by p53-SET interplay 34.12
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 34.08
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 34.06
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 34.06
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 33.91
DIGIT regulates endoderm differentiation of human embryonic stem cells 33.81
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 33.7
Gene expression changes upon drug withdrawal (Mel888 cell line) 33.25
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 33.17
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 32.65
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 32.64
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 32.64
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 32.52
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 32.45
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 32.45
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 32.36
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 32.05
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 31.96
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 31.96
Identification of the role of polydom in neurofibromas 31.69
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 31.6
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 31.29
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 30.94
MYCi975 regulates MYC target genes 30.91
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 30.69
Characterization of parental and rociletinib-resistant derived H1975 cell lines 30.54
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 30.46
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 30.43
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 30.41
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 30.28
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 29.89
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 29.89
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 29.79
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 29.75
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 29.7
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 29.57
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 29.51
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 29.46
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 29.4
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 29.33
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 29.26
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 29.21
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 28.98
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 28.93
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 28.88
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 28.88
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 28.67
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 28.67
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 28.64
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 28.37
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 28.36
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 28.19
Differential analysis of gene regulation at transcript resolution by RNA-Seq 28.19
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 28.15
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 28.12
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 28.11
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 27.99
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 27.96
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 27.89
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 27.77
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 27.77
Transcriptome profiling of Normal and Cancerous Prostate Cells 27.67
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 27.59
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 27.56
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 27.46
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 27.38
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 27.38
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 27.31
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 26.97
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 26.91
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 26.91
26.85
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 26.79
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 26.78
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 26.75
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 26.74
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 26.48
Regionally specified human pluripotent stem cell-derived astrocytes 26.38
Regulation of highly expressed hCINAP on translatome 26.34
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 26.33
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 26.33
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 26.28
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 26.27
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 26.14
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 26.04
High level DNA repair gene expression in human ES cells 25.93
The effect of PPARG inhibition on human angiomyolipoma cells 25.87
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 25.84
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 25.84
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 25.83
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 25.75
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 25.68
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 25.56
CircRNAome diversity in human mature B-cells, T-cells and monocytes 25.36
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 25.18
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 24.93
Transcriptome analysis of Zika infected neural stem cells 24.88
Zika infected neural stem cells 24.88
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 24.86
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 24.85
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 24.74
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 24.68
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 24.68
Gene expression profiling of human and murine in vitro muscle differentiation 24.6
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 24.36
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 24.32
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 24.22
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 24.15
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 23.91
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 23.83
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 23.79
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 23.78
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 23.77
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 23.68
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 23.67
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 23.39
A sister of NANOG regulates genes expressed in pre-implantation human development 23.3
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 23.29
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 23.24
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 23.2
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 22.83
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 22.83
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 22.75
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 22.64
Spliceosomal disruption of the non-canonical BAF complex in cancer 22.63
CHD1 regulates cell fate determination by activation of differentiation-induced genes 22.53
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 22.28
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 22.28
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 22.17
Gene expression changes in human melanoma cell lines compared to primary melanocytes 22.16
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 22.16
RNA-seq of cells with TET1 knockout 21.83
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 21.69
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 21.52
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 21.52
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 21.44
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 21.44
Aging-associated patterns in the expression of human endogenous retroviruses 21.36
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 21.32
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 21.21
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 21.15
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 21.15
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 20.9
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 20.9
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 20.88
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 20.85
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 20.82
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 20.79
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 20.78
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 20.73
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 20.66
CDK12 mediated transcriptional regulation in U2OS cells 20.61
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 20.44
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 20.38
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 20.35
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 20.27
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 20.27
circRNA profile in hypopharyngeal cancer 20.18
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 19.98
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 19.97
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 19.92
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 19.7
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 19.7
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 19.68
RNA-seq of resting and activated CD4+ T cells +-JQ1 19.65
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 19.56
An RNA-centric dissection of host complexes controlling flavivirus infection 19.42
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 19.42
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 19.39
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 19.39
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 19.18
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 19.16
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 19.13
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 19.08
Hijacking of stress response machinery by oncogenes in acute leukaemia 19.08
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 18.98
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 18.92
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 18.92
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 18.9
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 18.78
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 18.73
MEIS1 regulates hematopoiesis in hPSCs 18.73
Maturation of human iNSCs 18.67
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 18.67
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 18.57
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 18.52
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 18.49
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 18.49
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 18.41
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 18.38
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 18.37
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 18.32
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 18.27
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 18.14
RNA-seq of stable and unstable section of human atherosclerotic plaques 18.1
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 18.08
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 18.08
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 18.08
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 17.99
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 17.86
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 17.85
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 17.85
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 17.83
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 17.8
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 17.8
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 17.43
Transcriptome of activated human and mouse MAIT cells 17.01
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 16.91
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 16.82
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 16.77
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 16.77
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 16.77
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 16.77
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 16.71
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 16.71
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 16.69
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 16.61
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 16.61
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 16.53
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 16.45
MARCKS and lnc-MARCKS act as inflammation regulators 16.39
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 16.38
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 16.29
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 16.29
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 16.06
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 15.92
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 15.88
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 15.82
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 15.77
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 15.62
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 15.62
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 15.61
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 15.41
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 15.33
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 15.13
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 14.92
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 14.71
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 14.46
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 14.32
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 14.21
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 14.08
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 14.08
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.07
RNA-seq of naive and primed ES cells 14.04
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 13.88
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 13.85
High-Throughput Kinetic Analysis of Fractional Killing 13.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 13.62
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 13.62
Targeted enhancer activation by a subunit of the integrator complex 13.56
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 13.31
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 13.22
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 13.07
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 13.06
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 13.06
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 12.98
CHCHD10 gene KO effect in iPSC drived motor neurons 12.92
PGE2 mediated gene expression changes in human cervical stromal cells 12.9
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 12.85
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 12.82
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 12.81
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 12.77
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 12.63
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 12.63
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 12.63
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 12.6
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 12.57
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 12.57
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.27
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 12.11
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 12.11
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 12.0
RNA-seq of CD33 KO and control HSPCs 11.97
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 11.86
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  11.82
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 11.82
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 11.42
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 11.4
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 11.3
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 11.28
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 11.28
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 11.05
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 10.97
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 10.94
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 10.77
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 10.76
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 10.76
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 10.76
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 10.63
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 10.58
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 10.46
Regulatory network controlling tumor-promoting inflammation in human cancers 10.46
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 10.39
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 10.39
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 10.39
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 10.25
Gene expression profile of multiple myeloma cell lines treated with CB-5083 10.05
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 10.02
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 10.02
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 9.96
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 9.85
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 9.8
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.71
Transcriptional dependencies in diffuse intrinsic pontine glioma 9.62
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 9.6
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 9.43
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 9.33
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 9.25
Macrophage Ad5f35 PhenoMap 9.11
Recovery and analysis of nascent RNA 8.73
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 8.73
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 8.67
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 8.62
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.56
Molecular Criteria for Defining the Naive Human Pluripotent State 8.39
Transcriptome analysis of human lung epithelial cells 8.35
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 8.31
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 8.3
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 8.22
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 8.22
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 7.87
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 7.71
RNA sequencing analysis of selumetinib-resistant CRC cells lines 7.69
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 7.67
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.67
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 7.61
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 7.27
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 7.22
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 6.87
Iron response of HepG2 cells 6.86
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 6.83
RNA-Seq in neutrophils from Antiphospholipid Syndrome 6.8
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 6.69
NHLRC1 re-expression in cancer cells 6.66
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 6.64
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 6.6
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 6.48
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.34
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.2
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 6.05
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.04
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 5.9
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 5.9
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 5.47
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 5.43
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 5.42
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 5.28
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 5.26
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 5.26
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 5.19
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 5.1
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 5.04
Gene expression profile of human iPSC-derived nephron progenitor cells 4.99
Activity-dependent transcriptional changes in human neurons 4.97
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 4.88
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 4.88
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.78
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 4.77
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 4.58
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 4.58
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 4.56
Copper Regulation of HIF-1 Transcription Activity 4.56
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 4.36
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.31
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.25
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 4.24
BMS-470539 on human synovial fibroblasts 4.03
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.9
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 3.8
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.78
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.77
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.72
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.65
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.58
RNAseq of Breast cancer PDX samples 3.56
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.55
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.53
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 3.46
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 3.42
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.32
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 3.22
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 3.14
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 3.03
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 2.95
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.71
Effects of transcription on genome - nuclear lamina interactions 2.71
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.62
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 2.4
Transcriptome-wide response to synthetic chromatin protein PcTF 2.36
Transcriptome analyses of human pancreatic islets and pseudoislets 2.16
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 2.13
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.07
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 2.03
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.98
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.96
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.9
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 1.79
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.72
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.47
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.45
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.4
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.4
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.4
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.29
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.17
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.16
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.12
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.06
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.94
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.8
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.61
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.46
CHCHD2 gene KO effect in iPSC drived motor neurons 0.32
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.26
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.17
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.11
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.1
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.1
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation